Oxford BioDynamics' new CEO on what surprised him from the inside, the August fundraise, and why EpiSwitch Orion is now a commercial platform.

Custom prostate cancer awareness uniforms, supported by Oxford BioDynamics, help Clarksburg 11U youth football start conversations about men's health, family history, and early detection.

Dr. Garrett Pohlman, a board-certified urologist, discusses how EpiSwitch® PSE fits into real-world prostate cancer evaluation, biopsy decision-making, billing, patient conversations, and clinic workflow.

"Every once in a while, a breakthrough shows up that causes physicians to stop and say, 'Hey, this changes everything.'"

Dr. Garrett Pohlman delivers Podium Presentation #1 at the Global Prostate Cancer Congress, highlighting real-world integration of EpiSwitch® PSE in large urology practices

Access to the EpiSwitch® PSE prostate cancer detection blood test continues to expand to more healthcare providers and patients.

Dr “Med Man” Quinn has released a thoughtful and highly accessible video explaining the EpiSwitch PSE blood test and why it is poised to change the way we test for prostate cancer.

A new generation of minimally invasive and highly precise diagnostic tools is reshaping the landscape of cancer care.

June was Men's Health Month, and there is no better moment to spotlight the crucial issue of early detection of prostate cancer

Prostate cancer doesn't always come with early symptoms, which is why this blog explains who's at risk, the limitations of PSA testing, and how newer, more accurate blood tests are helping to detect cancer earlier—when it's most treatable.

EpiSwitch® PSE cancer screening test leverages the interaction between cancer cells and immune cells in the bloodstream

The EpiSwitch® CiRT transforms the liver cancer treatment landscape by using epigenetic molecular biomarkers located in immune cells to assess each patient's unique profile.

We had the privilege to sit down with Coach Kiven Williams, who has turned his family's battle with prostate cancer into a powerful mission on and off the field.

Episodes 107-109 of this podcast explain how the EpiSwitch CiRT blood test stands out by evaluating a cancer patient's immune system readiness to work with checkpoint immunotherapy to fight their cancer.

Although it affects all men, Black men are twice as likely to develop prostate cancer. Can the gap be closed?

Oxford BioDynamics was honored to serve as a local sponsor for the Houston ZERO Prostate Cancer Run/Walk.

Patient Advocacy Groups (PAGs) play a crucial role in the holistic care and support of prostate cancer patients.

Discover how a first-of-its-kind blood test is transforming cancer care by predicting immunotherapy success with unparalleled accuracy without the need for invasive tissue biopsies.

What if we told you there's a game-changing method for detecting prostate cancer that's as simple as a routine blood test?

Step into the innovative world of cancer research with a recent blog post by Here to Serve, a beacon of support for families navigating the challenging journey of a cancer diagnosis.

We are delighted to share an exclusive episode of The Prostate Health Podcast featuring our distinguished Laboratory Medical Director, Dr. Robert Heaton.

As November begins, we shift our focus to raising awareness about men's health during Movember.

In October, we focus on Breast Cancer Awareness Month, where communities join hands to support and raise awareness about breast cancer.

Adopting a one-size-fits-all approach leads to many patients being prescribed medicines that do not work for them.